# Continuous Femoral Nerve Block With a Tibial Plateau Fracture

> **NCT02168959** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Utah** · enrollment: 5 (actual)

## Conditions studied

- Tibial Plateau Fracture

## Interventions

- **DRUG:** bupivacaine

## Key facts

- **NCT ID:** NCT02168959
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2016-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02168959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02168959, "Continuous Femoral Nerve Block With a Tibial Plateau Fracture". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02168959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*